Home Newsfeeds Oppenheimer Initiates Coverage On D.R. Horton with Perform Rating

Oppenheimer Initiates Coverage On D.R. Horton with Perform Rating

Oppenheimer analyst Tyler Batory initiates coverage on D.R. Horton (NYSE:DHI) with a Perform rating.

byBenzinga Newsdesk

January 19, 2023

1 minute read

Oppenheimer analyst Tyler Batory initiates coverage on D.R. Horton (NYSE:DHI) with a Perform rating.

Analyst Ratings

5 Analysts Have This to Say About E2open Parent Holdings

By Benzinga Insights

June 8, 10:01 AM

E2open Parent Holdings (NYSE:ETWO) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent…

ETWO

Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales

By Avi Kapoor

January 5, 3:30 PM

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 50 points on Friday. The Dow traded up 0.13% to 37,490.36 while the NASDAQ rose 0.25% to 14,546.77. The S&P 500 also rose, gaining, 0.26% to 4,701.05.

AGL

Orchid Island Capital Announces One-for-five Reverse Stock Split

By Benzinga Newsdesk

August 18, 8:55 AM

One-for-five reverse stock split of the outstanding shares of Common Stock August 2022 Monthly Dividend of $0.16 Per Share of Common Stock RMBS Portfolio Characteristics as of July 31, 2022 Next

ORC

Fennec Pharmaceuticals Has Also Been Granted A CMS Permanent Product-Specific Reimbursement J-code (J0208) For Pedmark Effective April 1, 2023

By Happy Mohamed

February 13, 3:30 PM

https://www.cms.gov/files/document/2022-hcpcs-application-summary-quarter-4-2022-drugs-and-biologicals-updated-02/01/2023.pdf

FENC

Oppenheimer Initiates Coverage On D.R. Horton with Perform Rating

Related Posts

5 Analysts Have This to Say About E2open Parent Holdings

Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat Sales

Orchid Island Capital Announces One-for-five Reverse Stock Split

Fennec Pharmaceuticals Has Also Been Granted A CMS Permanent Product-Specific Reimbursement J-code (J0208) For Pedmark Effective April 1, 2023